Articles and Editorials|

Applications of deep learning in medical device manufacturing

Tad News Content 1920x630@2x

In the August issue of ONdrugDelivery magazine, SHL’s Frederick Gertz, Manager of Data Process and Innovation, and Gilbert FluetschDirector of Automation Systems, discusses how deep learning can boost the manufacturing landscape in the medical device industry.  

In this article, thauthors shed light on the development of deep learningexplaining its evolution from machine learning, and bringing attention to how it can be applied to optimize SHL’s production processes. Drawing from SHL’s own experience with vision inspection systems, Gertz and Fluetsch detail the technical implementations behind deep learning applications on existing automation machinery. In leveraging SHL’s wealth of data generated over years of camera vision inspection on sub-assembly parts during productionthe data innovation team shows an example of how to deploy deep learning models for detecting component defects with historical data and within a shorter amount of time. According to the authors, With 30 minutes of work and a relatively small amount of data, the algorithm was able to provide a very high degree of confidence in its ability to segregate good images from bad.  

Demonstrations from real-world examples cited in the article allow readers to have a clearer understanding of how deep learning is applied in SHL’s manufacturing environment.  

To read the full article, please click here. Or, download here.

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News